Articles From: Power Integrations Reports Third-Quarter Financial Results to POZEN’s YOSPRALA™ Receives Complete Response Letter from The FDA


Power Integrations (Nasdaq: POWI ) today announced financial results for the quarter ended September 30, 2014.
Sign-up for Power Integrations Reports Third-Quarter Financial Results investment picks
Power Integrations (Nasdaq: POWI ), the leader in high-voltage integrated circuits for energy-efficient power conversion, today announced a new class of power-supply ICs.
Sign-up for Power Integrations Revolutionizes Switch-Mode Power-Supply Design by Launching the InnoSwitch Family of Switcher ICs investment picks
Power Integrations (Nasdaq: POWI ) will release its fourth-quarter financial results after market hours on Wednesday, February 4, 2015.
Sign-up for Power Integrations to Announce Fourth-Quarter Financial Results on February 4 investment picks
As heavy rain continues to impact the region, Southern California Edison (SCE) has power outages scattered throughout its service area, and crews are working to restore service as safely and quickly as possible.
Sign-up for Power Outages Scattered Throughout SCE’s Service Territory; Crews Working Around the Clock to Restore Power investment picks
2014/12/13
More Than Half a Million Impacted by Wind, Rain and Snow Now Have Lights Back On SAN FRANCISCO , Dec.
Sign-up for Power Restored To Nearly All Customers After Historic Storm investment picks
WOOD DALE, Ill., Jan.
Sign-up for Power Solutions International to Present at 17th Annual Needham Growth Conference investment picks
Net sales up 45% year over year, 13% sequentially WOOD DALE, Ill., Nov.
Sign-up for Power Solutions International, Inc. Reports Third Quarter 2014 Results investment picks
2014/10/30
The collaborative efforts of Hill+Knowlton Strategies and Bisqit in Norway and the Norwegian Agency for Development Cooperation (Norad) earned recognition as the Platinum SABRE Best in Show at the Global SABRE Awards program last night in Miami for their project, “ Born Again .” In addition, the firm’s team in Australia and its Cancer Council client were recognized as runner up for the same award for their work developing the “ I Touch Myself ” project, an integrated campaign produced in collaboration with JWT to promote the early detection of breast cancer.
Sign-up for Powerful “Born Again” Project Named Best in Show at Global SABRE Awards investment picks
2014/11/24
By Amir Mizroch An extremely sophisticated computer spying program has been spying on computers in Saudi Arabia, Russia, and other countries since at least 2008, security company Symantec says.
Sign-up for Powerful new cyber-spying program discovered investment picks
PEABODY, Mass., Nov.
Sign-up for Powerful, New bk3000 Ultrasound System Featured at RSNA investment picks
--Distributed generation business continues to gain momentum--
Sign-up for PowerSecure Adds $10 Million In New Business investment picks
WAKE FOREST, N.C. , Oct.
Sign-up for PowerSecure Adds $15 Million In New Business investment picks
--Wins in all three segments to start 2015--
Sign-up for PowerSecure Adds $15 Million In New Business investment picks
--Management realignment sharpens focus on revenue and profit growth without adding headcount--
Sign-up for PowerSecure Realigns Leadership Team To Strengthen Operational Focus And Enhance Profitabilty Of Expected Growth investment picks
WAKE FOREST, N.C. , Nov.
Sign-up for PowerSecure Reports Third Quarter 2014 Results investment picks
WAKE FOREST, N.C. , Jan.
Sign-up for PowerSecure to Present at the 17th Annual Needham Growth Conference investment picks
WAKE FOREST, N.C. , Nov.
Sign-up for PowerSecure To Present At Upcoming Investor Conference investment picks
WAKE FOREST, N.C. , Dec.
Sign-up for PowerSecure Wins New Data Center Business investment picks
2015/1/20
PowerShares Canada announces cash distributions for TSX-listed ETFs Canada NewsWire TORONTO , Jan.
Sign-up for PowerShares Canada announces cash distributions for TSX-listed ETFs investment picks
2015/1/16
PowerShares Canada to terminate two ETFs Canada NewsWire TORONTO , Jan.
Sign-up for PowerShares Canada to terminate two ETFs investment picks
http://media.marketwire.com/attachments/201105/26522_investcopowersharesNAVYlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1165702&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for PowerShares Multi-Strategy Alternative Portfolio (LALT) Receives William F. Sharpe Award for ETF Innovation of the Year investment picks
2015/1/8
Robust, integrated program will help training journalists in the "Newsroom of the Future" ST.
Sign-up for Poynter and Gannett Join Forces to Create Transformative Journalism Training Program investment picks
POZEN Inc. (NASDAQ: POZN) , a pharmaceutical company committed to transforming medicine that transforms lives, announced today that it plans to release third quarter 2014 results on November 6, 2014, before the market opens.
Sign-up for POZEN Announces November 6th Webcast of Third Quarter 2014 Results investment picks
POZEN Inc. (NASDAQ: POZN) , a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it has received three patents from the United States Patent and Trademark Office (USPTO), entitled “Pharmaceutical Compositions for the Coordinated Delivery of NSAIDs” that cover the U.S. approved product VIMOVO ® (naproxen / esomeprazole magnesium) delayed-release tablets.
Sign-up for POZEN Announces Receipt of Three Patents from the United States Patent and Trademark Office investment picks
POZEN Inc. (NASDAQ: POZN) , a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it and Sanofi US have mutually agreed to terminate their agreement for commercialization of the investigational products, PA8140 and PA32540 effective November 29, 2014.
Sign-up for POZEN Inc. and Sanofi US Mutually Agree to Terminate U.S. Partnership for PA8140/PA32540 investment picks
POZEN Inc. (NASDAQ: POZN) , a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the third quarter ended September 30, 2014.
Sign-up for POZEN Reports Third Quarter 2014 Results investment picks
POZEN Inc. (NASDAQ: POZN) , a pharmaceutical company committed to transforming medicine that transforms lives, announced today that their investigational drug candidates YOSPRALA™ 81/40 and 325/40 (aspirin / omeprazole delayed release tablets) have received a second complete response letter (CRL) from the U.S. Food and Drug Administration (FDA). A CRL is issued by the FDA when the review of the file is completed and questions remain that preclude the approval of the new drug application (NDA) in its current form.
Sign-up for POZEN’s YOSPRALA™ Receives Complete Response Letter from The FDA investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Power Integrations Reports Third-Quarter Financial Results to POZEN’s YOSPRALA™ Receives Complete Response Letter from The FDA
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent